Darcy G. Mott - 20 Sep 2021 Form 4 Insider Report for HEALTHEQUITY, INC. (HQY)

Role
Special Advisor
Signature
/s/ Darcy G. Mott
Issuer symbol
HQY
Transactions as of
20 Sep 2021
Net transactions value
-$232,344
Form type
4
Filing time
21 Sep 2021, 14:06:46 UTC
Previous filing
24 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HQY Common Stock Options Exercise $140,000 +10,000 +11% $14.00* 97,052 20 Sep 2021 Direct F1
transaction HQY Common Stock Sale $351,249 -5,665 -5.8% $62.00 91,387 20 Sep 2021 Direct F1, F2
transaction HQY Common Stock Sale $21,095 -335 -0.37% $62.97 91,052 20 Sep 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HQY Stock Option (right to buy) Options Exercise $0 -10,000 -33% $0.000000 20,000 20 Sep 2021 Common Stock 10,000 $14.00 Direct F1, F3
holding HQY Stock Option (right to buy) 25,000 20 Sep 2021 Common Stock 25,000 $25.39 Direct F3
holding HQY Stock Option (right to buy) 19,897 20 Sep 2021 Common Stock 19,897 $41.28 Direct F3
holding HQY Stock Option (right to buy) 14,228 20 Sep 2021 Common Stock 14,228 $61.72 Direct F4
holding HQY Stock Option (right to buy) 15,337 20 Sep 2021 Common Stock 15,337 $73.61 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Darcy G. Mott is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.53 to $62.51, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) of this Form 4.
F3 The option is immediately exercisable.
F4 The option is exercisable as to 10,671 shares. The remaining 3,557 options vest on March 27, 2022.
F5 The option is exercisable as to 7,669 shares. The remaining options vest as to 3,834 shares on each of March 27, 2022 and 2023.